# LIGAND PHARMACEUTICALS INC CON COM

LIGAND PHARMACEUTICALS INC CON COM is a security (CUSIP 532CNT029) tracked across SEC portfolio filings. 1 institutional managers reported positions on Form 13F as of 2026-06-30; 2 registered fund positions totaling $0 via N-PORT as of 2026-05-29.

## Summary

- Issuer: LIGAND PHARMACEUTICALS INC CON
- Class: COM
- CUSIP: 532CNT029
- Asset category: EC
- 13F holders: 1
- 13F period: 2026-06-30
- N-PORT fund positions: 2
- N-PORT value: $0
- N-PORT report: 2026-05-29

## Top institutional holders (Form 13F)

| Manager | Location | Value | Shares |
| --- | --- | --- | --- |
| [Sterling Capital Management LLC](https://search.stillhousedata.com/firm/135405) | CHARLOTTE, NC | — | 23 |

## Top fund holders (N-PORT)

| Fund | Registrant | Value | % of fund |
| --- | --- | --- | --- |
| Guggenheim Active Allocation Fund | Guggenheim Active Allocation Fund | $0 | 0.00% |
| [Vericimetry U.S. Small Cap Value Fund](https://search.stillhousedata.com/fund/S000033942) | VERICIMETRY FUNDS | — | — |

## More

- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/security/532CNT029.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.